Tradestie Institutional Equity Comparison Engine

SNYR vs ABUS โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ABUS Overall Edge

ABUS Captures Institutional Edge (3โ€“1 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Arbutus Biopharma Corporation Common Stock (ABUS) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while SNYR counters with relative strength in Valuation. Fundamentally, SNYR trades at 0.6x Forward P/E with -10.3% operating margin (-32.8% YoY revenue) versus ABUS at 10.2x Forward P/E and 80.1% operating margin (-43.5% YoY). In options structure, SNYR sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ABUS sits in CONSOLIDATION (18th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner SNYR
SNYR 0.6x vs ABUS 10.2x Fwd P/E
Growth & Margin Winner ABUS
Op Margin -10.3% vs 80.1% ยท YoY -32.8% vs -43.5%
Momentum & Technical Winner ABUS
1Y -96.2% vs -5.8% ยท 52W Pos 1% vs 27%
Options & Structure Winner ABUS
UNCLASSIFIED (N/A IV) vs CONSOLIDATION (18th %ile IV)
SNYR NASDAQ
Synergy CHC Corp. Common Stock
Medicinal Chemicals & Botanical Products
$0.09
-67.02% 1D
Market Cap $4.1M
1M Return -16.28%
1Y Return -96.15%
Forward P/E 0.6x
Unified AI Score
48.9 / 100 HOLD
Tech 55.0 Fund 39.0 Flow 50.0 Mom 60.0
ABUS NASDAQ
Arbutus Biopharma Corporation Common Stock
Pharmaceutical Preparations
$4.02
-1.23% 1D
Market Cap $623.9M
1M Return -4.51%
1Y Return -5.85%
Forward P/E 10.2x
Unified AI Score
43.4 / 100 HOLD
Tech 28.0 Fund 48.0 Flow 68.0 Mom 53.7

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: SNYR -96.15% ABUS -5.85% Spread: +114.87 pp (ABUS Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period SNYR Revenue ABUS Revenue SNYR Op. Margin ABUS Op. Margin Margin Edge
FY2018 $30M $10M -14.5% -1510.2% SNYR
FY2019 $30M $10M -27.1% -2394.0% SNYR
FY2020 N/A $10M N/A -836.1% ABUS
FY2021 N/A $10M N/A -669.1% ABUS
FY2022 N/A $40M N/A -167.8% ABUS
FY2023 $40M $20M 25.3% -430.5% SNYR
FY2024 $30M $10M 16.7% -1236.7% SNYR
FY2025 $30M $10M -27.8% -271.0% SNYR

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: SNYR (4) vs ABUS (6)
Institutional Metric SNYR ABUS Criterion Row Winner
Market Capitalization Scale $4.1M $623.9M Larger Scale ABUS
Trailing P/E Ratio Valuation 0.6x 3.6x Lower Multiple SNYR
Forward P/E Ratio Valuation 0.6x 10.2x Lower Multiple SNYR
Revenue Growth (YoY) Growth -32.8% -43.5% Higher Growth SNYR
Operating Margin (TTM) Profitability -10.3% 80.1% Higher Margin ABUS
Net Profit Margin Profitability -57.0% 121.2% Higher Margin ABUS
Return on Equity (ROE) Capital Efficiency -361.1% 269.6% Higher ROE ABUS
52-Week Range Position Momentum 1% ($0โ€“$3) 27% ($4โ€“$5) Stronger Trend ABUS
Beta / 30D Volatility Risk Regime -0.86ฮฒ ยท 868% Vol 1.04ฮฒ ยท 48% Vol Lower Realized Risk ABUS
Unified Institutional Score Composite Signal 48.9 / 100 (HOLD) 43.4 / 100 (HOLD) Higher Composite SNYR

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full SNYR vs ABUS Buy Guide
SNYR UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live SNYR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ABUS CONSOLIDATION
96d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 18th %ile
IV Regime Compressed (<25th %ile)
Live ABUS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither SNYR nor ABUS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.